AI assistant
Insight Molecular Diagnostics Inc. — Director's Dealing 2016
Feb 18, 2016
34238_dirs_2016-02-18_49b93639-277f-4dae-8a29-97a61248e83d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2016-02-16
Reporting Person: CHAPMAN KAREN B. (Vice President of Research)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-16 | Option to Purchase Common Stock | $3.06 | A | 60000 | Acquired | 2026-02-15 | Common Stock (60000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $2.20 | 2025-01-08 | Common Stock (100000) | 100000 | Direct |
| Option to Purchase Common Stock | $1.50 | 2018-03-31 | Common Stock (200000) | 200000 | Direct |
| Option to Purchase Common Stock | $2.20 | 2025-01-08 | Common Stock (125000) | 125000 | Indirect |
| Option to Purchase Common Stock | $1.34 | 2020-12-28 | Common Stock (250000) | 250000 | Indirect |
Footnotes
F1: One quarter of the options shall vest on February 15, 2017, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant.
F2: One quarter of the options vested on January 8, 2016 upon the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant.
F3: 1/48th of the number of options vested and became exercisable at the end of each full month of employment after the date of grant on April 1, 2011.
F4: One quarter of the options granted to Michael West vested on January 8, 2016, and the balance shall vest in 36 monthly installments from the first anniversary of the date of grant. Dr. West and Dr. Chapman are husband and wife.
F5: 1/48th of the number of options granted to Michael West vested and became exercisable at the end of each full month after the date of grant on December 29, 2010. Dr. West and Dr. Chapman are husband and wife.